PharmaTher Granted US Patent Protection for Ketamine
PharmaTher has received a Notice of Allowance from the United States Patent and Trademark Office (USPTO) covering use of…
Articles by Patricia Inácio, PhD
Mobile App Available to Provide Training on Parkinson’s D-mine Pump
EVER Pharma has launched a mobile app for the D-mine Pump, its portable micro-infusion pump designed to continuously deliver apomorphine under…
High Copper Exposure May Promote Disease-driving Protein Clumping
Exposure to high concentrations of copper accelerates the formation of toxic clumps of the alpha-synuclein protein — a hallmark of …
FDA Gives Green Light to Phase 3 Trial of Buntanetap
Annovis Bio has been given the go-ahead by the U.S. Food and Drug Administration (FDA) to begin…
Study Explores New Way to Monitor Neuroinflammation
Overactivation of microglia cells — known to drive neuroinflammation in diseases like Parkinson’s — can be detected by measuring a…
3-Month Boxing Program Found to Ease Motor, Nonmotor Symptoms
A tailored three-month boxing exercise program significantly eased both motor and nonmotor symptoms — including depression, anxiety, sleep problems, and…
Fujirebio Bolsters Its Parkinson’s Diagnostic Tools With Acquisition
Fujirebio Holdings’ portfolio of biomarkers and diagnostic tools for Parkinson’s disease now includes tailor-made antibodies against…
New LRRK2 Gene Mutations Linked With Familial Parkinson′s
Two new mutations in the LRRK2 gene have been identified as likely causes of familial Parkinson’s disease, a study reports.
Gut Microbiome of Patients Favors Inflammation, Study Suggests
People with Parkinson’s disease appear to have a gut microbiome — the population of microorganisms living in…
Dosing Begins in Phase 2b Study of Oral BIIB122/DNL151
A Phase 2b clinical trial evaluating the investigational oral therapy BIIB122/DNL151 for the treatment of people with Parkinson’s disease has started…